Home/Quanterix/Amir Ali Talasaz, Ph.D.

AA

Amir Ali Talasaz, Ph.D.

Chief Strategy Officer & President, Diagnostics

Therapeutic Areas

Neurology Oncology Immunology Cardiology Infectious Disease

Quanterix Pipeline

Drug	Indication	Phase
LucentAD Complete	Alzheimer's Disease Detection	FDA 510(k) Submission
p-tau 205 & p-tau 212 Assays	Alzheimer's Disease Research	Research Use
Neurology Biomarker Portfolio (GFAP, Nf-L)	Traumatic Brain Injury / Neurodegeneration	Clinical Research / LDT

Leadership Team at Quanterix

Masoud Toloue, Ph.D.

President & Chief Executive Officer

Michael J. Doyle

Chief Financial Officer

Brian J. Blaser

Chief Operating Officer

William (Bill) R. Donnelly

Chief Commercial Officer

David C. Duffy, Ph.D.

Chief Technology Officer

E. Kevin Hrusovsky

Founder & Executive Chairman

View full Quanterix profile